Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy-Reference-Cited by-同舟云学术

Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy

Published:2002-07 Issue:4 Volume:53 Page:880-888
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Buchholz Thomas A,Katz Angela,Strom Eric A,McNeese Marsha D,Perkins George H,Hortobagyi Gabriel N,Thames Howard D,Kuerer Henry M,Singletary S.Eva,Sahin Aysegul A,Hunt Kelly K,Buzdar Aman U,Valero Vicente,Sneige Nour,Tucker Susan L

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference20 articles.

1. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer;Lancet,2000

2. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy;Overgaard;N Engl J Med,1997

3. Postoperative radiotherapy in high risk postmenopausal breast cancer patients given adjuvant tamoxifen;Overgaard;Lancet,1999

4. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer;Ragaz;N Engl J Med,1997

5. The link between local recurrence and distant metastasis in human breast cancer;Koscielny;Int J Radiat Oncol Biol Phys,1999

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regional radiotherapy after primary systemic treatment for cN+ breast cancer patients;The Breast;2023-04

2. The impact of postmastectomy radiotherapy on cT1-2N1 breast cancer patients with ypN0 after neoadjuvant chemotherapy: a retrospective study based on real-world data;Discover Oncology;2023-01-07

3. Multidisciplinary considerations in the management of breast cancer patients receiving neoadjuvant chemotherapy;Current Problems in Surgery;2022-09

4. De-escalation of radiotherapy after primary chemotherapy in cT1–2N1 breast cancer (RAPCHEM; BOOG 2010–03): 5-year follow-up results of a Dutch, prospective, registry study;The Lancet Oncology;2022-09

5. A novel nomogram for predicting locoregional recurrence risk in breast cancer patients treated with neoadjuvant chemotherapy and mastectomy;Radiotherapy and Oncology;2021-08